down arrow

Essex Bio-Technology Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG312371035
HKD
3.91
-0.04 (-1.01%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,669.82
1,736.97
1,317.71
1,637.66
978.11
1,279.48
1,176.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,669.82
1,736.97
1,317.71
1,637.66
978.11
1,279.48
1,176.46
Raw Material Cost
171.15
174.94
128.38
241.89
184.28
246.12
202.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
327.81
316.00
295.54
297.68
228.52
209.01
140.69
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.09
11.21
11.47
9.22
1.42
6.96
7.40
Selling and Distribution Expenses
1,125.70
1,183.70
892.85
969.10
572.86
709.89
709.39
Other Expenses
-30.89
-28.81
-28.35
-28.34
-22.14
-21.26
-13.00
Total Expenditure (Excl Depreciation)
1,321.86
1,397.78
1,044.74
1,234.51
765.73
959.42
930.43
Operating Profit (PBDIT) excl Other Income
348
339.20000000000005
273
403.1
212.39999999999998
320.09999999999997
246
Other Income
17.35
12.01
42.64
32.43
30.61
23.29
17.53
Operating Profit (PBDIT)
420.82
410.70
357.14
468.15
270.23
370.77
282.96
Interest
6.09
11.21
11.47
9.22
1.42
6.96
7.40
Exceptional Items
19.19
7.67
-43.60
-31.90
9.28
15.38
16.90
Gross Profit (PBDT)
1,498.66
1,562.03
1,189.33
1,395.77
793.83
1,033.35
973.54
Depreciation
55.51
59.51
41.53
32.57
27.23
27.42
19.41
Profit Before Tax
378.41
347.66
260.54
394.46
250.85
351.77
273.05
Tax
68.28
70.75
34.93
48.49
31.93
49.26
41.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
307.22
275.26
225.41
345.97
218.93
302.50
231.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
307.22
275.26
225.41
345.97
218.93
302.50
231.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
307.22
275.26
225.41
345.97
218.93
302.50
231.09
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
2,123.72
1,923.78
1,731.37
1,734.28
1,426.19
1,197.15
928.90
Earnings per share (EPS)
0.53
0.47
0.38
0.58
0.37
0.51
0.39
Diluted Earnings per share
0.53
0.47
0.38
0.58
0.37
0.51
0.39
Operating Profit Margin (Excl OI)
20.84%
19.53%
20.72%
24.62%
21.71%
25.01%
20.91%
Gross Profit Margin
25.99%
23.44%
22.92%
26.08%
28.43%
29.64%
24.86%
PAT Margin
18.4%
15.85%
17.11%
21.13%
22.38%
23.64%
19.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -3.87% vs 31.82% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 11.59% vs 22.14% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 1.20% vs 26.77% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -45.54% vs -2.61% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Essex Bio-Technology Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
1,669.82
472.66
1,197.16
253.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,669.82
472.66
1,197.16
253.28%
Raw Material Cost
171.15
194.49
-23.34
-12.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
327.81
429.04
-101.23
-23.59%
Power Cost
0
0
0.00
Manufacturing Expenses
6.09
51.89
-45.80
-88.26%
Selling and Distribution Expenses
1,125.70
551.82
573.88
104.00%
Other Expenses
-30.89
4.55
-35.44
-778.90%
Total Expenditure (Excl Depreciation)
1,321.86
1,272.71
49.15
3.86%
Operating Profit (PBDIT) excl Other Income
347.95
-800.04
1,147.99
143.49%
Other Income
17.35
-900.62
917.97
101.93%
Operating Profit (PBDIT)
420.82
-1,570.01
1,990.83
126.80%
Interest
6.09
51.89
-45.80
-88.26%
Exceptional Items
19.19
424.08
-404.89
-95.47%
Gross Profit (PBDT)
1,498.66
278.18
1,220.48
438.74%
Depreciation
55.51
130.65
-75.14
-57.51%
Profit Before Tax
378.41
-1,328.47
1,706.88
128.48%
Tax
68.28
-39.89
108.17
271.17%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
307.22
-1,229.98
1,537.20
124.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
307.22
-1,229.98
1,537.20
124.98%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
-74.82
74.82
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
307.22
-1,304.80
1,612.02
123.55%
Equity Capital
0
0
0.00
Face Value
0.10
1.12
0.00
Reserves
2,123.72
4,050.69
-1,926.97
-47.57%
Earnings per share (EPS)
0.53
-2.81
3.34
118.86%
Diluted Earnings per share
0.53
-2.81
3.34
118.86%
Operating Profit Margin (Excl OI)
20.84%
-169.26%
0.00
190.10%
Gross Profit Margin
25.99%
-253.42%
0.00
279.41%
PAT Margin
18.40%
-260.22%
0.00
278.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 166.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.87% vs 31.82% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 30.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.59% vs 22.14% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.35 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.20% vs 26.77% in Dec 2023

Annual - Interest
Interest 0.61 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -45.54% vs -2.61% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.84%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."